Eventide Asset Management, LLC Exact Sciences Corp Transaction History

Eventide Asset Management, LLC

  • $5.67 Billion
  • Q3 2024

A detailed history of Eventide Asset Management, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Eventide Asset Management, LLC holds 1,232,119 shares of EXAS stock, worth $70.7 Million. This represents 1.48% of its overall portfolio holdings.

Number of Shares
1,232,119
Previous 1,231,728 0.03%
Holding current value
$70.7 Million
Previous $52 Million 61.21%
% of portfolio
1.48%
Previous 0.92%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$42.43 - $70.83 $16,590 - $27,694
391 Added 0.03%
1,232,119 $83.9 Million
Q2 2024

Aug 13, 2024
BUY
$41.33 - $74.26 $6.08 Million - $10.9 Million
147,006 Added 13.55%
1,231,728 $52 Million
Q1 2024

May 15, 2024
BUY
$56.27 - $73.77 $79,284 - $103,941
1,409 Added 0.13%
1,084,722 $74.9 Million
Q4 2023

Feb 14, 2024
SELL
$59.06 - $75.72 $46.3 Million - $59.4 Million
-784,737 Reduced 42.01%
1,083,313 $80.1 Million
Q3 2023

Nov 14, 2023
BUY
$65.94 - $99.04 $22,155 - $33,277
336 Added 0.02%
1,868,050 $127 Million
Q2 2023

Aug 15, 2023
BUY
$62.68 - $95.05 $11,157 - $16,918
178 Added 0.01%
1,867,714 $175 Million
Q1 2023

May 15, 2023
BUY
$47.19 - $70.77 $8,069 - $12,101
171 Added 0.01%
1,867,536 $127 Million
Q3 2022

Nov 14, 2022
BUY
$31.97 - $49.37 $16 Million - $24.8 Million
501,765 Added 36.74%
1,867,365 $60.7 Million
Q2 2022

Aug 15, 2022
SELL
$35.61 - $76.23 $4.43 Million - $9.48 Million
-124,400 Reduced 8.35%
1,365,600 $53.8 Million
Q3 2021

Nov 15, 2021
SELL
$90.24 - $124.05 $22.6 Million - $31 Million
-250,000 Reduced 14.37%
1,490,000 $142 Million
Q2 2020

Aug 14, 2020
BUY
$55.75 - $92.75 $19.4 Million - $32.3 Million
348,000 Added 25.0%
1,740,000 $151 Million
Q1 2020

May 15, 2020
BUY
$37.9 - $104.44 $34 Million - $93.7 Million
897,000 Added 181.21%
1,392,000 $80.7 Million
Q2 2019

Aug 14, 2019
BUY
$89.51 - $118.04 $31.8 Million - $41.9 Million
355,000 Added 253.57%
495,000 $58.4 Million
Q1 2019

May 15, 2019
BUY
$61.98 - $96.5 $557,820 - $868,500
9,000 Added 6.87%
140,000 $12.1 Million
Q1 2018

May 15, 2018
BUY
$39.82 - $57.53 $1.23 Million - $1.78 Million
31,000 Added 31.0%
131,000 $5.28 Million
Q3 2017

Nov 14, 2017
BUY
$37.05 - $47.12 $3.7 Million - $4.71 Million
100,000
100,000 $4.71 Million

Others Institutions Holding EXAS

# of Institutions
674
Shares Held
163M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email